blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3324832

EP3324832 - SYSTEMS FOR LESION FORMATION AND ASSESSMENT [Right-click to bookmark this link]
Former [2018/22]SYSTEMS AND METHODS FOR LESION FORMATION AND ASSESSMENT
[2022/31]
StatusThe patent has been granted
Status updated on  02.12.2022
Database last updated on 26.06.2024
FormerGrant of patent is intended
Status updated on  14.07.2022
FormerRequest for examination was made
Status updated on  27.04.2018
FormerThe international publication has been made
Status updated on  27.01.2017
Most recent event   Tooltip18.06.2024New entry: Despatch of communication that patent is revoked 
Applicant(s)For all designated states
460Medical, Inc.
33 Huron Avenue
Cambridge, MA 02138 / US
[2019/40]
Former [2018/22]For all designated states
Luxcath, LLC
33 Arch Street
Suite 3201
Boston, Massachusetts 02110 / US
Inventor(s)01 / RANSBURY, Terrance J.
112 Simerville Road
Chapel Hill, North Carolina 27517 / US
02 / ARMSTRONG, Kenneth C.
104 Modena Drive
Cary, North Carolina 27513 / US
03 / AMIRANA, Omar
21 LilacCourt
Cambridge, Massachusetts 02141 / US
04 / LARSON, Cinnamon
1549 Pathway Drive
Carrboro, North Carolina 27510 / US
 [2018/22]
Representative(s)Nordmeyer, Philipp Werner
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstraße 16
80333 München / DE
[2018/22]
Application number, filing date16828397.619.07.2016
[2018/22]
WO2016US42891
Priority number, dateUS201562194276P19.07.2015         Original published format: US 201562194276 P
US20151491900421.10.2015         Original published format: US201514919004
[2018/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017015257
Date:26.01.2017
Language:EN
[2017/04]
Type: A1 Application with search report 
No.:EP3324832
Date:30.05.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 26.01.2017 takes the place of the publication of the European patent application.
[2018/22]
Type: B1 Patent specification 
No.:EP3324832
Date:04.01.2023
Language:EN
[2023/01]
Search report(s)International search report - published on:US26.01.2017
(Supplementary) European search report - dispatched on:EP20.02.2019
ClassificationIPC:A61B5/00, A61B18/02, A61B18/14, A61B18/24, A61N7/00, A61B90/30, A61B34/20
[2019/12]
CPC:
A61B90/30 (EP,KR,US); A61B17/00234 (EP,KR,US); A61B18/00 (CN);
A61B18/02 (EP,KR,US); A61B18/06 (EP,KR,US); A61B18/1206 (EP,KR,US);
A61B18/1492 (EP,KR,US); A61B18/1815 (EP,KR,US); A61B18/24 (EP,KR,US);
A61B5/0071 (CN); A61B5/0084 (CN); A61B5/4836 (CN);
A61B5/6852 (CN); A61B5/6869 (CN); A61B90/361 (EP,KR,US);
A61B90/37 (EP,KR,US); A61N7/00 (EP,KR,US); A61B2017/00057 (EP,KR,US);
A61B2017/00061 (EP,KR,US); A61B2018/00351 (EP,KR,US); A61B2018/00357 (EP,KR,US);
A61B2018/00363 (EP,KR,US); A61B2018/00375 (CN); A61B2018/00577 (EP,CN,KR,US);
A61B2018/0066 (EP,KR,US); A61B2018/00904 (CN); A61B2018/0091 (CN);
A61B2018/00982 (EP,CN,KR,US); A61B2018/00994 (EP,KR,US); A61B2018/0212 (EP,KR,US);
A61B2018/1861 (EP,KR,US); A61B2034/2051 (EP,KR,US); A61B2090/306 (EP,KR,US);
A61B2090/3614 (EP,KR,US); A61B2090/376 (EP,KR,US); A61B2218/002 (EP,KR,US) (-)
Former IPC [2018/22]A61B5/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/22]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:SYSTEME ZUR LÄSIONSBILDUNG UND BEWERTUNG[2022/31]
English:SYSTEMS FOR LESION FORMATION AND ASSESSMENT[2022/31]
French:SYSTÈMES POUR LA FORMATION ET L'ÉVALUATION DE LÉSIONS[2022/31]
Former [2018/22]SYSTEME UND VERFAHREN ZUR LÄSIONSBILDUNG UND BEWERTUNG
Former [2018/22]SYSTEMS AND METHODS FOR LESION FORMATION AND ASSESSMENT
Former [2018/22]SYSTÈMES ET PROCÉDÉS POUR LA FORMATION ET L'ÉVALUATION DE LÉSIONS
Entry into regional phase19.02.2018National basic fee paid 
19.02.2018Search fee paid 
19.02.2018Designation fee(s) paid 
19.02.2018Examination fee paid 
Examination procedure19.02.2018Examination requested  [2018/22]
19.02.2018Date on which the examining division has become responsible
18.09.2019Amendment by applicant (claims and/or description)
15.07.2022Communication of intention to grant the patent
25.11.2022Fee for grant paid
25.11.2022Fee for publishing/printing paid
25.11.2022Receipt of the translation of the claim(s)
Opposition(s)Opponent(s)01  04.10.2023  06.10.2023  ADMISSIBLE
Biorem AG
c/o Wirtschaftsprüfung Trevisca AG
Zugerstrasse 74
6340 Baar / CH
Opponent's representative
Felber, Josef
Felber & Partner AG
Dufourstrasse 116
8008 Zürich / CH
 [2023/46]
18.10.2023Invitation to proprietor to file observations on the notice of opposition
19.06.2024Despatch of communication that the patent will be revoked
Fees paidRenewal fee
11.07.2018Renewal fee patent year 03
15.07.2019Renewal fee patent year 04
23.07.2020Renewal fee patent year 05
28.07.2021Renewal fee patent year 06
28.07.2022Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
IT04.01.2023
LT04.01.2023
LV04.01.2023
MC04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SI04.01.2023
SK04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
LU19.07.2023
CH31.07.2023
[2024/26]
Former [2024/24]AT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
MC04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SI04.01.2023
SK04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
LU19.07.2023
CH31.07.2023
Former [2024/18]AT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
MC04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SI04.01.2023
SK04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
LU19.07.2023
Former [2024/14]AT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
MC04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SI04.01.2023
SK04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2024/11]AT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SI04.01.2023
SK04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2023/50]AT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SK04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2023/49]AT04.01.2023
CZ04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RO04.01.2023
RS04.01.2023
SE04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2023/48]AT04.01.2023
DK04.01.2023
EE04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RS04.01.2023
SE04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2023/46]AT04.01.2023
DK04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RS04.01.2023
SE04.01.2023
SM04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2023/39]AT04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RS04.01.2023
SE04.01.2023
NO04.04.2023
GR05.04.2023
IS04.05.2023
PT04.05.2023
Former [2023/38]AT04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
PL04.01.2023
RS04.01.2023
SE04.01.2023
NO04.04.2023
GR05.04.2023
PT04.05.2023
Former [2023/37]AT04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
RS04.01.2023
SE04.01.2023
NO04.04.2023
GR05.04.2023
PT04.05.2023
Former [2023/36]AT04.01.2023
ES04.01.2023
FI04.01.2023
HR04.01.2023
LT04.01.2023
LV04.01.2023
NL04.01.2023
RS04.01.2023
SE04.01.2023
NO04.04.2023
PT04.05.2023
Former [2023/35]AT04.01.2023
ES04.01.2023
HR04.01.2023
LT04.01.2023
NL04.01.2023
RS04.01.2023
NO04.04.2023
PT04.05.2023
Former [2023/34]ES04.01.2023
LT04.01.2023
NL04.01.2023
RS04.01.2023
PT04.05.2023
Former [2023/33]ES04.01.2023
LT04.01.2023
NL04.01.2023
Former [2023/31]NL04.01.2023
Documents cited:Search[Y]US2006089636  (CHRISTOPHERSON MARK A [US], et al);
 [Y]US2007270717  (TANG JING [US], et al);
 [X]US2009131931  (LEE JAMES K [US], et al);
 [XY]EP2889013  (BIOSENSE WEBSTER ISRAEL LTD [IL]);
 [PX]WO2016073492  (LUXCATH LLC [US])
International search[Y]US2006089636  (CHRISTOPHERSON MARK A [US], et al) [Y] 10/(1-2,4-8) 21/(12-13,15- 19), 35/(23-27,29-33), 37, 38 * ; entire dooumont, ocpecially Abstract; Fig. 1. *;
 [A]US2006122587  (SHARAREH SHIVA [US]) [A] 1-28* ; entire document. *;
 [XYA]US2009131931  (LEE JAMES K [US], et al) [X] 1-2, 4-5, (9,11)/(1-2,4-8), 12-13, 15-19, (20, 22)/(12 -13, 15-19) * ; entire document, especially Figs. 1, 4A, 7; paras. [0013], [0050]-[0055], [0059], [0065], [0078]. * [Y] 10/(1-2,4-8), 21/(12-13,15 -19), 23-27, 29-33, (34- 36)/(23-27,29-33), 37-38 [A] 3, 9-11/(3), 14, (20- 22)/(14), 28, (34-36)/(28);
 [YA]US2013102862  (MERCADER MARCO A [US], et al) [Y] 23-27, 29-33, (34-36)/(23- 27,29-33) * ; entire document, especially Figs. 1A-C, 3; 11B; para. [0052]-[0058], [0061], [0071]-[0076], [0099]. * [A] 28, (34-36)/(28);
 [A]US2014088418  (RADULESCU EMIL [US], et al) [A] 1-28 * ; entire document, especially Fig. 4B, para. [0053], [0055]. *
by applicantUS2006089636
 US2007270717
 US2009131931
 EP2889013
OppositionUS6485413
 US2003125719
 US2006089636
 US2006122587
 US2007179487
 US2007270717
 US2008021275
 US7417740
 US2009131931
 US2010081873
 JP2012052882
 US2013023865
 US2013102862
 US2014088418
 WO2014205256
 US2014378846
 EP2889013
 US9087368
 US9186066
 WO2016073492
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.